Inventor · disambiguated record
Erick Goldman
Also filed as: GOLDMAN ERICK · GOLDMAN ERICK A
25 granted patents·28 pending applications·1,168 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
53 records- 0199US9725455B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Aug 8, 2017·25 cites·13 claims
- 0299US9713617B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted Jul 25, 2017·28 cites·41 claims
- 0398US10125140B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Nov 13, 2018·18 cites·4 claims
- 0498US9828383B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Nov 28, 2017·20 cites·31 claims
- 0598US9296753B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Mar 29, 2016·84 cites·18 claims
- 0698US7342013B2Benzamides and related inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2006·Granted Mar 11, 2008·45 cites·16 claims
- 0798US7285565B2Benzamides and related inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2005·Granted Oct 23, 2007·171 cites·8 claims
- 0898US6844367B1Benzamides and related inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2000·Granted Jan 18, 2005·142 cites·10 claims
- 0998US6835739B2Benzamides and related inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2003·Granted Dec 28, 2004·131 cites·11 claims
- 1098US6376515B2Benzamides and related inhibitors of factor XaCOR THERAPEUTICS INC·Filed 2001·Granted Apr 23, 2002·247 cites·72 claims
- 1197US10961251B1Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·14 claims
- 1297US10294231B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·11 cites·28 claims
- 1397US10106548B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Oct 23, 2018·13 cites·30 claims
- 1497US9540382B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Jan 10, 2017·43 cites·31 claims
- 1597US8691847B2Benzamides and related inhibitors of factor XaZHU BING-YAN·Filed 2012·Granted Apr 8, 2014·28 cites·11 claims
- 1697US7727981B2Benzamides and related inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2007·Granted Jun 1, 2010·23 cites·10 claims
- 1797US7727982B2Benzamides and related inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2006·Granted Jun 1, 2010·19 cites·12 claims
- 1896US10294232B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·9 cites·29 claims
- 1996US10065968B2Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Sep 4, 2018·10 cites·22 claims
- 2095US10752634B2Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·3 cites·28 claims
- 2195US8063036B2Benzamides and related inhibitors of factor XaZHU BING-YAN·Filed 2010·Granted Nov 22, 2011·11 cites·20 claims
- 2294US10266540B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Apr 23, 2019·5 cites·23 claims
- 2393US7312235B2Benzamide inhibitors of factor XaMILLENNIUM PHARM INC·Filed 2002·Granted Dec 25, 2007·40 cites·20 claims
- 2489US7022695B2Thioether-substituted benzamides as inhibitors of Factor XaMILLENNIUM PHARM INC·Filed 2004·Granted Apr 4, 2006·36 cites·30 claims
- 2588US2025197404A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 2688US2024409545A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 2786US8518977B2Benzamides and related inhibitors of factor XAZHU BING-YAN·Filed 2011·Granted Aug 27, 2013·2 cites·3 claims
- 2884US2024158400A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 2979US2022112196A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 3077US2021032258A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 3176US2019248799A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 3276US2019248798A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 3375US2020347063A1Solvated forms of a bruton?s tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 3475US2020231595A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 3575US2020148691A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 3673US2022098200A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 3772US2022106317A1Solvated forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 3872US2020347064A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 3972US2018155352A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 4072US2018170940A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 4171US2017305919A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 4270US2014336203A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 4369US2022242868A1Co-crystals of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 4468US2019367518A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 4561US2019367519A1Solvated forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 4661US2018009814A1Synthesis of a bruton?s tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 4758US2020031829A1Co-crystals of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 4854US2018072738A1Solvated forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 4954US2003162690A1Benzamides and related inhibitors of factor XaCOR THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 5052US2013197230A1Methods of preparing quinoline derivativesWILSON JO ANN·Filed 2009·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →